BBS Bioactive Debt To Equity vs. Current Valuation
| BONEH Stock | EUR 0.07 0 1.47% |
For BBS Bioactive profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BBS Bioactive to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BBS Bioactive Bone Substitutes utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BBS Bioactive's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BBS Bioactive Bone Substitutes over time as well as its relative position and ranking within its peers.
BBS |
BBS Bioactive Bone Current Valuation vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BBS Bioactive's current stock value. Our valuation model uses many indicators to compare BBS Bioactive value to that of its competitors to determine the firm's financial worth. BBS Bioactive Bone Substitutes is number one stock in debt to equity category among its peers. It also is the top company in current valuation category among its peers reporting about 14,723,890 of Current Valuation per Debt To Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value BBS Bioactive by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BBS Bioactive's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BBS Current Valuation vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
BBS Bioactive |
| = | 0.99 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
BBS Bioactive |
| = | 14.53 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
BBS Current Valuation vs Competition
BBS Bioactive Bone Substitutes is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is currently estimated at about 555.07 Million. BBS Bioactive holds roughly 14.53 Million in current valuation claiming about 2.62% of all equities under Medical Devices industry.
BBS Bioactive Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BBS Bioactive, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BBS Bioactive will eventually generate negative long term returns. The profitability progress is the general direction of BBS Bioactive's change in net profit over the period of time. It can combine multiple indicators of BBS Bioactive, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. The company was founded in 2003 and is headquartered in Oulu, Finland. BBS Bioactive is traded on Helsinki Exchange in Finland.
BBS Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BBS Bioactive. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BBS Bioactive position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BBS Bioactive's important profitability drivers and their relationship over time.
Use BBS Bioactive in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BBS Bioactive position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BBS Bioactive will appreciate offsetting losses from the drop in the long position's value.BBS Bioactive Pair Trading
BBS Bioactive Bone Substitutes Pair Trading Analysis
The ability to find closely correlated positions to BBS Bioactive could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BBS Bioactive when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BBS Bioactive - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BBS Bioactive Bone Substitutes to buy it.
The correlation of BBS Bioactive is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BBS Bioactive moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BBS Bioactive Bone moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BBS Bioactive can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BBS Bioactive position
In addition to having BBS Bioactive in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Basic Utilities Thematic Idea Now
Basic Utilities
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BBS Stock
To fully project BBS Bioactive's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BBS Bioactive Bone at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BBS Bioactive's income statement, its balance sheet, and the statement of cash flows.